Results 61 to 70 of about 49,735 (302)

Inebilizumab in AQP4‐Seropositive NMOSD: One‐Year Follow‐Up From a Multicenter, Real‐World Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Real‐world evidence on inebilizumab among neuromyelitis optica spectrum disorder (NMOSD) patients is lacking. This study assessed inebilizumab among Chinese patients with aquaporin 4 autoantibody (AQP4‐IgG)‐seropositive NMOSD in a real‐world setting.
Mengcui Gui, Jiayang Zhan, Wei Li, Tao Jin, Dan He, Daishi Tian, Zhijun Li, Jing Lin, Yue Li, Hongyu Zhou, Bitao Bu   +10 more
wiley   +1 more source

Management of BK Virus Nephropathy with IVIG in a Kidney Transplant Recipient Unresponsive to Immunosuppression Reduction

Mediterranean Journal of Infection, Microbes and Antimicrobials
BK virus (BKV)-associated nephropathy (BKVN) is a complication that can lead to graft loss after kidney transplantation. The primary approach to this disease is reduction of immunosuppressive therapy; however, some cases are non-responsive to this ...
Davut Eren, Sümeyra Koyuncu, Fatoş Tekelioğlu, Esma Eryılmaz Eren, Ramazan Önalan, Koray Uludağ   +5 more
doaj   +1 more source

The Comprehensive Live Cell‐Based Cytotoxicity Assay for Monitoring Disease Activity and Guiding Rescue Therapy in Acute Attacks of NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a devastating neurological disease that lacks serological biomarkers that can accurately reflect disease activity. We established a live cell‐based assay (LCBA) using serum with endogenous complement to quantify the overall cytotoxicity, offering a novel functional tool for monitoring
Xiaona Xu, Jie Ding, Yupeng Du, Guibao Luo, Jinming Li, Rui Liu, Xiaoyi Xu, Xiao Li, Minshu Li, Wei Jiang, Chunsheng Yang   +10 more
wiley   +1 more source

Postępy w badaniach nad mechanizmem działania IVIg [PDF]

, 2010
Cząsteczka IgG stanowi główny składnik dożylnych preparatów immunoglobulin (IVIg, intravenous immune globulin). Komercyjne preparaty IVIg pochodzą od grupy dawców, w wyniku czego zawierają również niewielkie ilości przeciwciał IgA, IgM, a także cytokiny ...
Hartung, Hans-Peter; Department of Neurology, Heinrich-Heine-University, Duesseldorf, Niemcy
core  

Ofatumumab Therapy and Long‐Term Seizure Outcomes of Patients With Relapsing Anti‐NMDA Receptor Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There is a lack of studies on seizure outcomes associated with ofatumumab therapy in patients for relapsing anti‐N‐methyl‐D‐aspartate (NMDA) receptor encephalitis. We aimed to evaluate long‐term seizure outcomes of ofatumumab therapy for relapsing anti‐NMDA receptor encephalitis.
Jian Wang, Mengjiao Li, Ping Kong
wiley   +1 more source

Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical Practice

Journal of Blood Medicine, 2021
Fei Song,1,2 Hanny Al-Samkari2,3 1Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; 2Harvard Medical School, Boston, MA, USA; 3Division of Hematology, Massachusetts General Hospital, Boston, MA, USACorrespondence: Hanny Al ...
Song F, Al-Samkari H
doaj  

IVIg therapy and gene expression analysis.

, 2013
Eight additional CVID subjects were tested before and 5-7 days after receiving IVIg. Individual transcripts (567) were selected by Welch ANOVA test (MTC: Benjamini and Hochberg, FDR, p-cutoff
Virginia Pascual (130037), Indira Munagala (459538), Jacques Banchereau (4187), Joon Park (459537), Charlotte Cunningham-Rundles (379344), Hui Xu (9203), Damien Chaussabel (26369), Derek Blankenship (173502), Patrick Maffucci (459539)   +8 more
core   +1 more source

Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort Study

Neurology and Therapy, 2023
Introduction Intravenous immunoglobulin (IVIG) is recommended as first-line therapy for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), an immune-mediated neuropathy.
J. Bradley Layton, Mary E. Ritchey, Zhongwen Huang, Shailesh Chavan, Hakan Ay, Nizar Souayah, Colin Anderson-Smits   +6 more
doaj   +1 more source

Association of Elevated Platelets and C‐Reactive Protein With Severe Disease and Poor Survival in Systemic Sclerosis

Arthritis Care &Research, EarlyView.
Objective Elevated C‐reactive protein (CRP) levels in systemic sclerosis (SSc) have been linked with severe disease and worse survival, but the role of platelet levels remains unclear. This study examined whether elevated platelet levels, CRP levels, or both are associated with disease severity, progression, and survival in SSc.
Brian S. Lee, Shufeng Li, Srijana Davuluri, Jennifer Lee, Lorinda Chung   +4 more
wiley   +1 more source

Outcome of Patients with Gullain Barre syndrome at Tertiary Care Hospital in Eastern Nepal

Journal of Nobel Medical College, 2018
Background: Gullain Barre syndrome is the most common cause of acute flaccid paralysis. Early diagnosis and treatment improves survival in patients with Gullain Barre Syndrome.
Dilli Ram Kafle, Surendra Shah
doaj   +1 more source